The Potential Role of the Gut–Vascular Axis in Ciprofloxacin-Associated Aggravation of Aortic Dissection
Cardiovascular Toxicology · 2026
DOI: 10.1007/s12012-026-10196-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Toxicology, 2026. Verfasst von Hui Lv und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Shanghai Dongfang Hospital, Shanghai Tongji University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Ciprofloxacin, Muscle, Smooth, Vascular, Myocytes, Smooth Muscle, Gastrointestinal Microbiome. Die Arbeit nennt 51 Literaturangaben. Gefördert von: the National Natural Science Foundation of China, the National Natural Science, the Natural Science Foundation of Xinjiang Uygur Autonomous Region.
Abstract (Originalsprache)
Ciprofloxacin (CIP) is associated with an increased risk of aortic dissection (AD); however, the underlying mechanism remains unclear. This study investigates the potential contribution of gut microbiota and intestinal barrier alterations to CIP-associated AD progression. The AD model was established using a combination of β-aminopropionitrile and angiotensin II. The composition of the gut microbiota was analyzed using 16 S rRNA sequencing. In vivo experiments were conducted to investigate whether CIP aggravates AD through a potential gut-vascular axis involving intestinal alterations and increased circulating lipopolysaccharide (LPS) levels, which was further explored in human aortic smooth muscle cells (HASMCs). The results showed that CIP aggravated aortic injury and induced smooth muscle cell dysfunction in AD mice. CIP disrupted gut microbial composition and impaired intestinal barrier integrity, which was accompanied by increased circulating LPS levels. Additionally, in vitro experiments demonstrated that combined CIP and LPS stimulation enhanced HASMC apoptosis and phenotypic switching. Our findings suggest that CIP-associated intestinal alterations and elevated circulating LPS levels may contribute to AD progression through a potential gut-vascular axis, providing new insights into fluoroquinolone-associated vascular injury and potential gut-targeted interventions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, Shanghai Dongfang Hospital, Shanghai Tongji University School of Medicine, Shanghai, China.
- Department of Cardiology, Shandong Provincial Hospital, Shandong First Medical University, Jinan, Shandong, China.
- Department of Cardiology, The First Affiliated Hospital of Xinjiang Medical University, Xinjiang Medical University, Ürümqi, Xinjiang, China.
- Department of Cardiology, People's Hospital of Xinjiang Uygur Autonomous Region, Ürümqi, Xinjiang, China.
- Department of Cardiology, Changji Branch of the First Affiliated Hospital of Xinjiang Medical University, Xinjiang Medical University, Changji, Xinjiang, China.
- Department of Cardiology, The First Affiliated Hospital of Xinjiang Medical University, Xinjiang Medical University, Ürümqi, Xinjiang, China. maxiang123@xjmu.edu.cn.
Förderung
- the National Natural Science Foundation of China
- the National Natural Science
- the Natural Science Foundation of Xinjiang Uygur Autonomous Region
Zitieren
APA
Lv, H., Wang, Q., Abudesimu, A., Yesitayi, G., Aizitiaili, A., Siti, D., & Ma, X. (2026). The Potential Role of the Gut–Vascular Axis in Ciprofloxacin-Associated Aggravation of Aortic Dissection. Cardiovascular Toxicology. https://doi.org/10.1007/s12012-026-10196-7
Vancouver
Lv H, Wang Q, Abudesimu A, Yesitayi G, Aizitiaili A, Siti D, et al. The Potential Role of the Gut–Vascular Axis in Ciprofloxacin-Associated Aggravation of Aortic Dissection. Cardiovascular Toxicology. 2026. doi:10.1007/s12012-026-10196-7
BibTeX
@article{Lv2026,
author = {Lv, Hui and Wang, Qi and Abudesimu, Asiya and Yesitayi, Gulinazi and Aizitiaili, Aliya and Siti, Dilixiati and Ma, Xiang},
title = {The Potential Role of the Gut–Vascular Axis in Ciprofloxacin-Associated Aggravation of Aortic Dissection},
journal = {Cardiovascular Toxicology},
year = {2026},
doi = {10.1007/s12012-026-10196-7}
}
EUVIMED